BenQ Medical Technology Capital Reinvestment Ratio
BenQ Medical Technology capital reinvestment ratio. BenQ Medical Technology (4116) has a Capital Reinvestment Ratio of 0.06x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$148.51 Million) in capital expenditures (NT$9.28 Million). Check BenQ Medical Technology investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BenQ Medical Technology (2017–2025)
Capital reinvestment ratio of BenQ Medical Technology from 2017 to 2025. This chart tracks BenQ Medical Technology's Capital Reinvestment Ratio across 9 annual periods. Also explore BenQ Medical Technology equity growth rate to track the company's year-over-year net asset growth rate.
BenQ Medical Technology Capital Reinvestment Ratio by Year (2017–2025)
BenQ Medical Technology capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see BenQ Medical Technology operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | NT$358.75 Million | NT$99.24 Million | ▼ -65.0% |
| 2024 | 0.79x | NT$222.22 Million | NT$175.48 Million | ▲ +150.8% |
| 2023 | 0.31x | NT$442.35 Million | NT$139.28 Million | ▲ +98.6% |
| 2022 | 0.16x | NT$378.77 Million | NT$60.05 Million | ▼ -41.6% |
| 2021 | 0.27x | NT$121.35 Million | NT$32.92 Million | ▼ -3.0% |
| 2020 | 0.28x | NT$151.48 Million | NT$42.37 Million | ▲ +123.8% |
| 2019 | 0.12x | NT$169.23 Million | NT$21.15 Million | ▼ -49.8% |
| 2018 | 0.25x | NT$126.10 Million | NT$31.36 Million | ▼ -83.8% |
| 2017 | 1.54x | NT$72.97 Million | NT$112.31 Million | — |